Skip to main content
Log in

Electroconvulsive therapy transformed by the correct choice of anaesthetic drugs for the individual patient

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Table I

References

  1. Tharyan P, Adams CE. Electroconvulsive therapy for schizophrenia. Cochrane Database Syst Rev 2002; (2): CD000076

    PubMed  Google Scholar 

  2. Wagner KJ, Möllenberg O, Rentrop M, Werner C, Kochs EF. Guide to anaesthetic selection for electroconvulsive therapy. CNS Drugs 2005; 19:(9) 745–58

    Article  PubMed  Google Scholar 

  3. Ding Z, White PF. Anesthesia for electroconvulsive therapy. Anesth Analg 2002 May; 94(5): 1351–64

    Article  PubMed  Google Scholar 

  4. Abrams R. Electroconvulsive therapy. 3rd ed. N w York: Oxford University Press, 1997

    Google Scholar 

  5. Wells DG, Davies GG. Hemodynamic changes associated with electroconvulsive therapy. Anesth Analg 1987; 66(11): 1193–5

    Article  PubMed  CAS  Google Scholar 

  6. Fu W, Stool LA, White PF, et al. Acute hemodynamic responses to electroconvulsive therapy are not related to the duration of seizure activity. J Clin Anesth 1997; 9(8): 653–7

    Article  PubMed  CAS  Google Scholar 

  7. Saito S, Kadoi Y, Iriuchijima N, et al. Reduction of cerebral hyperemia with anti-hypertensive medication after electroconvulsive therapy. Can J Anaesth 2000; 47(8): 767–74

    Article  PubMed  CAS  Google Scholar 

  8. Bader GM, Silk KR, Dequardo JR, et al. Electroconvulsive therapy and intracranial aneurysm. Convuls Ther 1995; 11(2): 139–43

    PubMed  CAS  Google Scholar 

  9. Naguib M, Koorn R. Interactions between psychotropics, anaesthetics and electroconvulsive therapy: implications for drug choice and patient management. CNS Drugs 2002; 16(4): 229–47

    Article  PubMed  CAS  Google Scholar 

  10. Bouckoms AJ, Welch CA, Drop LJ, et al. Methohexital dosage in electroconvulsive therapy. Convuls Ther 1989; 5(1): 44–7

    PubMed  Google Scholar 

  11. British national formulary No. 50 [online]. Available from URL:http://www.bnf.org [Accessed 2006 Mar 5]

  12. Rxlist [online]. Available from URL:http://www.rxlist.com/ [Accessed 2006 Mar 5]

  13. Saito S, Kadoi Y, Naro T, et al. The comparative effects of propofol versus thiopental on middle cerebral artery blood flow velocity during electroconvulsive therapy. Anesth Analg 2000; 91(6): 1531–6

    Article  PubMed  CAS  Google Scholar 

  14. Conca A, Germann R, Konig P. Etomidate vs thiopentone in electroconvulsive therapy: an interdisciplinary challenge for anesthesiology and psychiatry. Pharmacopsychiatry 2003; 36(3): 94–7

    Article  PubMed  CAS  Google Scholar 

  15. Loimer N, Hofmann P, Chaudhry HR. Midazolam shortens seizure duration following electroconvulsive therapy. J Psychiatr Res 1992; 26(2): 97–101

    Article  PubMed  CAS  Google Scholar 

  16. Tanaka N, Saito Y, Hikawa Y, et al. Effects of thiopental and sevoflurane on hemodynamics during anesthetic management of electroconvulsive therapy [in Japanese]. Masui 1997; 46(12): 1575–9

    PubMed  CAS  Google Scholar 

  17. Van Den Berg AA, Honjol NM. Electroconvulsive therapy and intraocular pressure. Middle East J Anesthesiol 1998; 14(4): 249–58

    Google Scholar 

  18. Kelway B, Simpson KH, Smith RJ, et al. Effects of atropine and glycopyrrolate on cognitive function following anaesthesia and electroconvulsive therapy (ECT). Int Clin Psychopharmacol 1986; 1(4): 296–302

    Article  PubMed  CAS  Google Scholar 

  19. McCall WV. Antihypertensive medications and ECT. Convuls Ther 1993; 9(4): 317–25

    PubMed  Google Scholar 

  20. Stoudemire A, Knos G, Gladson M, et al. Labetalol in the control of cardiovascular responses to electroconvulsive therapy in high-risk depressed medical patients. J Clin Psychiatry 1990; 51(12): 508–12

    PubMed  CAS  Google Scholar 

  21. Weinger MB, Partridge BL, Hauger R, et al. Prevention of the cardiovascular and neuroendocrine response to electroconvulsive therapy: I. Effectiveness of pretreatment regimens on hemodynamics. Anesth Analg 1991; 73(5): 556–62

    PubMed  CAS  Google Scholar 

  22. Fu W, Stool LA, White PF, et al. Is oral clonidine effective in modifying the acute hemodynamic response during electroconvulsive therapy? Anesth Analg 1998; 86(5): 1127–30

    PubMed  CAS  Google Scholar 

  23. Blanch J, Martinez-Palli G, Navines R, et al. Comparative hemodynamic effects of urapidil and labetalol after electroconvulsive therapy. J ECT 2001; 17(4): 275–9

    Article  PubMed  CAS  Google Scholar 

  24. Wajima Z, Yoshikawa T, Ogura A, et al. Intravenous verapamil blunts hyperdynamic responses during electroconvulsive therapy without altering seizure activity. Anesth Analg 2002; 95(2): 400–2

    PubMed  CAS  Google Scholar 

  25. Wells DG, Davies GG, Rosewarne F. Attenuation of electroconvulsive therapy induced hypertension with sublingual nifedipine. Anaesth Intensive Care 1989; 17(1): 31–3

    PubMed  CAS  Google Scholar 

  26. Figiel GS, DeLeo B, Zorumski CF, et al. Combined use of labetalol and nifedipine in controlling the cardiovascular response from ECT. J Geriatr Psychiatry Neurol 1993; 6(1): 20–4

    PubMed  CAS  Google Scholar 

  27. Nguyen TT, Chhibber AK, Lustik SJ, et al. Effect of methohexitone and propofol with or without alfentanil on seizure duration and recovery in electroconvulsive therapy. Br J Anaesth 1997; 79(6): 801–3

    Article  PubMed  CAS  Google Scholar 

  28. Andersen FA, Arsland D, Holst-Larsen H. Effects of combined methohexitone-remifentanil anaesthesia in electroconvulsive therapy. Acta Anaesthesiol Scand 2001; 45(7): 830–3

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Electroconvulsive therapy transformed by the correct choice of anaesthetic drugs for the individual patient. Drugs Ther. Perspect 22, 12–16 (2006). https://doi.org/10.2165/00042310-200622060-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200622060-00004

Navigation